Cenveo Announces Agreement to sell its Packaging Business to WestRock

Cenveo, Inc. today announced that its wholly-owned subsidiary, Cenveo Corporation, and certain of its other subsidiaries have entered into a definitive agreement to sell the Company's packaging business to a division of WestRock Company, a leading provider of paper and packaging solutions in consumer and corrugated markets globally.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Cenveo, Inc. (the "Company") today announced that its wholly-owned subsidiary, Cenveo Corporation, and certain of its other subsidiaries have entered into a definitive agreement to sell the Company's packaging business to a division of WestRock Company ("WestRock"), a leading provider of paper and packaging solutions in consumer and corrugated markets globally. The sale involves six facilities located in the U.S., Canada and Dominican Republic along with strategic sourcing partnerships in Asia and the Caribbean that provide folded carton, shrink sleeve and lithographic laminated display packaging solutions ("Packaging Business").

Robert G. Burton, Sr., Chairman and Chief Executive Officer stated:
"The agreement brings conclusion to the review process of our Packaging Business which we started in the summer of 2015. The sale allows the Company to focus management's efforts on its core operations, specifically our envelopes, labels, and commercial print segments where we hold leading market positions. The transaction will generate significant cash for the Company, an important step in our stated plan to deleverage our balance sheet, improve cash flows, and address certain debt maturities. Additionally, the agreement is expected to provide the Company access to one of the leading global packaging companies in the United States via a proposed commercial arrangement."

The cash purchase price for the Packaging Business is approximately $105 million, subject to certain adjustments set forth in the agreement. The transaction is subject to regulatory approval and is expected to close in early 2016.

Barclays acted as exclusive financial advisor and Hughes Hubbard & Reed acted as legal advisor to the Company.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report